Effect of acute aldosterone administration on gene expression profile in the heart

Endocrinology

Volumn 147, Issue 7, 2006, Pages 3183-3189

  Turchin, Alexander ^a   Guo, Christine Z ^a   Adler, Gail K ^a   Ricchiuti, Vincent ^a   Kohane, Isaac S ^b   Williams, Gordon H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CORTICOSTERONE; DNA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATASE; PLACEBO; REACTIVE OXYGEN METABOLITE; STRUCTURAL PROTEIN;

ALDOSTERONE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAYES THEOREM; COMPUTER ANALYSIS; COMPUTER PROGRAM; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DNA MICROARRAY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENE INACTIVATION; HEART MUSCLE FIBROSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; REBOUND; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHAM FEEDING; SPECIES COMPARISON; STEROIDOGENESIS; VALIDATION STUDY;

ALDOSTERONE; ANIMALS; BAYES THEOREM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEART; MALE; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MYOCARDIUM; REACTIVE OXYGEN SPECIES; RNA, MESSENGER;

EID: 33745129067     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2005-1674     Document Type: Article

References (47)

1. Selye H 1946 The general adaptation syndrome and the diseases of adaptation. J Clin Endocrinal Metab 6:117-230
2. Rossi GP, Sacchetto A, Visentin P, Canali C, Graniero GR, Palatini P, Pessina AC 1996 Changes in left ventricular anatomy and function in hypertension and primary aldosteronism. Hypertension 27:1039-1045
3. Rossi GP, Sacchetto A, Pavan E, Palatini P, Graniero GR, Canali C, Pessina AC 1997 Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma. Circulation 95:1471-1478
4. Rossi GP, Di Bello V, Ganzaroli C, Sacchetto A, Cesari M, Bertini A, Giorgi D, Scognamiglio R, Mariani M, Pessina AC 2002 Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism. Hypertension 40:23-27
5. Arora RB 1965 Role of aldosterone in myocardial infarction. Ann NY Acad Sci 118:539-554
6. Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L 1990 Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation 82:1730-1736
7. Brilla CG, Weber KT 1992 Mineralocorticoid excess, dietary sodium, and myocardial fibrosis. J Lab Clin Med 120:893-901
8. Brilla CG, Weber KT 1992 Reactive and reparative myocardial fibrosis in arterial hypertension in the rat. Cardiovasc Res 26:671-677
9. Young M, Head G, Funder J 1995 Determinants of cardiac fibrosis in experimental hypermineralocorticoid states. Am J Physiol 269:E657-E662
10. Sun Y, Ramires FJ, Weber KT 1997 Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion. Cardiovasc Res 35:138-147
11. Qin W, Rudolph AE, Bond BR, Rocha R, Blomme EA, Goellner JJ, Funder JW, McMahon EG 2003 Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure. Circ Res 93:69-76
12. Rocha R, Stier Jr CT, Kifor I, Ochoa-Maya MR, Rennke HG, Williams GH, Adler GK 2000 Aldosterone: a mediator of myocardial necrosis and renal arteriopathy. Endocrinology 141:3871-3878
13. Brilla CG, Matsubara LS, Weber KT 1993 Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism. J Mol Cell Cardiol 25:563-575
14. Brilla CG, Matsubara LS, Weber KT 1993 Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension. Am J Cardiol 71:12A-16A
15. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J 1999 The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341:709-717
16. Pitt B, Reichek N, Willenbrock R, Zannad F, Phillips RA, Roniker B, Kleiman J, Krause S, Burns D, Williams GH 2003 Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study. Circulation 108:1831-1838
17. White PC 2003 Aldosterone: direct effects on and production by the heart. J Clin Endocrinol Metab 88:2376-2383
18. Ikeda U, Hyman R, Smith TW, Medford RM 1991 Aldosterone-mediated regulation of Na+, K(+)-ATPase gene expression in adult and neonatal rat cardiocytes. J Biol Chem 266:12058-12066
19. Cole TJ, Wong S, Alexiadis M, Tan K, Characterization of aldosterone-modulated target genes in mouse heart by cDNA subtraction and microarray analysis. Proc 31st Annual Meeting of the International Aldosterone Conference, San Diego, CA, 2005, p 22 (Abstract 21)
20. Reis BY, Butte AS, Kohane IS 2001 Extracting knowledge from dynamics in gene expression. J Biomed Inform 34:15-27
21. Holter NS, Maritan A, Cieplak M, Fedoroff NV, Banavar JR 2001 Dynamic modeling of gene expression data. Proc Natl Acad Sci USA 98:1693-1698
22. Aach J, Church GM 2001 Aligning gene expression time series with time warping algorithms. Bioinformatics 17:495-508
23. Ramoni MF, Sebastiani P, Kohane IS 2002 Cluster analysis of gene expression dynamics. Proc Natl Acad Sci USA 99:9121-9126
24. Edgar R, Domrachev M, Lash AE 2002 Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30:207-210
25. Barrett T, Suzek TO, Troup DB, Wilhite SE, Ngau WC, Ledoux P, Rudnev D, Lash AE, Fujibuchi W, Edgar R 2005 NCBI GEO: mining millions of expression profiles - database and tools. Nucleic Acids Res 33:D562-D566
26. Asyali MH, Shoukri MM, Demirkaya O, Khabar KS 2004 Assessment of reliability of microarray data and estimation of signal thresholds using mixture modeling. Nucleic Acids Res 32:2323-2335
27. Velculescu VE, Madden SL, Zhang L, Lash AE, Yu J, Rago C, Lal A, Wang CJ, Beaudry GA, Ciriello KM, Cook BP, Dufault MR, Ferguson AT, Gao Y, He TC, Hermeking H, Hiraldo SK, Hwang PM, Lopez MA, Luderer HF, Mathews B, Petroziello JM, Polyak K, Zawel L, Kinzler KW, et al 1999 Analysis of human transcriptomes. Nat Genet 23:387-388
28. Lee J, Hever A, Willhite D, Zlotnik A, Hevezi P 2005 Effects of RNA degradation on gene expression analysis of human postmortem tissues. FASEB J 19:1356-1358
29. Binder R, Horowitz JA, Basilion JP, Koeller DM, Klausner RD, Harford JB 1994 Evidence that the pathway of transferrin receptor mRNA degradation involves an endonucleolytic cleavage within the 3′ UTR and does not involve poly(A) tail shortening. EMBO J 13:1969-1980
30. Krozowski ZS, Funder JW 1983 Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity. Proc Natl Acad Sci USA 80:6056-6060
31. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM 1987 Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237:268-275
32. Naray-Fejes-Toth A, Fejes-Toth G 1990 Glucocorticoid receptors mediate mineralocorticoid-like effects in cultured collecting duct cells. Am J Physiol 259:F672-F678
33. Funder JW, Pearce PT, Myles K, Roy LP 1990 Apparent mineralocorticoid excess, pseudohypoaldosteronism, and urinary electrolyte excretion: toward a redefinition of mineralocorticoid action. FASEB J 4:3234-3238
34. Rocha R, Rudolph AE, Frierdich GE, Nachowiak DA, Kekec BK, Blomme EA, McMahon EG, Delyani JA 2002 Aldosterone induces a vascular inflammatory phenotype in the rat heart. Am J Physiol Heart Circ Physiol 283:H1802-H1810
35. Tu Y, Stolovitzky G, Klein U 2002 Quantitative noise analysis for gene expression microarray experiments. Proc Natl Acad Sci USA 99:14031-14036
36. Theodosiou A, Ashworth A 2002 MAP kinase phosphatases. Genome Biol 3:REVIEWS3009
37. Andreeva AV, Kutuzov MA 1999 RdgC/PP5-related phosphatases: novel components in signal transduction. Cell Signal 11:555-562
38. Manegold JC, Falkenstein E, Wehling M, Christ M 1999 Rapid aldosterone effects on tyrosine phosphorylation in vascular smooth muscle cells. Cell Mol Biol (Noisy-le-grand) 45:805-813
39. Rossol-Haseroth K, Zhou Q, Braun S, Boldyreff B, Falkenstein E, Wehling M, Losel RM 2004 Mineralocorticoid receptor antagonists do not block rapid ERK activation by aldosterone. Biochem Biophys Res Commun 318:281-288
40. Gasdaska PY, Berggren MM, Berry MJ, Powis G 1999 Cloning, sequencing and functional expression of a novel human thioredoxin reductase. FEBS Lett 442:105-111
41. Kundu GC, Mantile G, Miele L, Cordella-Miele E, Mukherjee AB 1996 Recombinant human uteroglobin suppresses cellular invasiveness via a novel class of high-affinity cell surface binding site. Proc Natl Acad Sci USA 93:2915-2919
42. Young MJ, Moussa L, Dilley R, Funder JW 2003 Early inflammatory responses in experimental cardiac hypertrophy and fibrosis: effects of 11β-hydroxysteroid dehydrogenase inactivation. Endocrinology 144:1121-1125
43. Robert V, Silvestre JS, Charlemagne D, Sabri A, Trouve P, Wassef M, Swynghedauw B, Delcayre C 1995 Biological determinants of aldosterone-induced cardiac fibrosis in rats. Hypertension 26:971-978
44. Garnier A, Bendall JK, Fuchs S, Escoubet B, Rochais F, Hoerter J, Nehme J, Ambroisine ML, De Angelis N, Morineau G, d'Estienne P, Fischmeister R, Heymes C, Pinet F, Delcayre C 2004 Cardiac specific increase in aldosterone production induces coronary dysfunction in aldosterone synthase-transgenic mice. Circulation 110:1819-1825
45. Brennan FE, Fuller PJ 2000 Rapid upregulation of serum and glucocorticoid-regulated kinase (sgk) gene expression by corticosteroids in vivo. Mol Cell Endocrinol 166:129-136
46. Bhargava A, Fullerton MJ, Myles K, Purdy TM, Funder JW, Pearce D, Cole TJ 2001 The serum- and glucocorticoid-induced kinase is a physiological mediator of aldosterone action. Endocrinology 142:1587-1594
47. Kendziorski CM, Zhang Y, Lan H, Attie AD 2003 The efficiency of pooling mRNA in microarray experiments. Biostatistics 4:465-477